These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26800092)

  • 21. Inclusion body myositis: from genetics to clinical trials.
    Nagy S; Khan A; Machado PM; Houlden H
    J Neurol; 2023 Mar; 270(3):1787-1797. PubMed ID: 36399165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of hyperbaric oxygen on inclusion body myositis.
    Pell M; Saththasivam P; Stephens PL; Mychaskiw G
    Undersea Hyperb Med; 2012; 39(6):1111-4. PubMed ID: 23342768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ; Amato AA
    Neurol Clin; 2014 Aug; 32(3):595-628, vii. PubMed ID: 25037081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
    Salam S; Dimachkie MM; Hanna MG; Machado PM
    Clin Exp Rheumatol; 2022 Feb; 40(2):384-393. PubMed ID: 35225226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion body myositis with early onset: a population-based study.
    Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
    J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of inclusion body myositis.
    Cherin P
    Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.
    Larue S; Maisonobe T; Benveniste O; Chapelon-Abric C; Lidove O; Papo T; Eymard B; Dubourg O
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):674-7. PubMed ID: 20562458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on treatment of inclusion body myositis.
    Breithaupt M; Schmidt J
    Curr Rheumatol Rep; 2013 May; 15(5):329. PubMed ID: 23529584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two emerging phenotypes of atypical inclusion body myositis: illustrative cases.
    Salam S; Morrow JM; Howard R; Miller JAL; Quinlivan RM; Machado PM
    Clin Exp Rheumatol; 2023 Mar; 41(2):340-347. PubMed ID: 36861744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A; Daniels BH; Lee HS; Margeta M
    Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.
    Garand KLF; Malandraki GA; Dimachkie MM
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):362-367. PubMed ID: 37678324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune inflammatory myopathies.
    Dalakas MC
    Handb Clin Neurol; 2023; 195():425-460. PubMed ID: 37562881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular occlusion training for inclusion body myositis: a novel therapeutic approach.
    Gualano B; Ugrinowitsch C; Neves M; Lima FR; Pinto AL; Laurentino G; Tricoli VA; Lancha AH; Roschel H
    J Vis Exp; 2010 Jun; (40):. PubMed ID: 20548279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment.
    Schmidt K; Schmidt J
    Curr Opin Rheumatol; 2017 Nov; 29(6):632-638. PubMed ID: 28832349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sporadic Inclusion Body Myositis].
    Yamashita S
    Brain Nerve; 2023 Jul; 75(7):869-874. PubMed ID: 37431078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion body myositis: an underdiagnosed myopathy of older people.
    Munshi SK; Thanvi B; Jonnalagadda SJ; Da Forno P; Patel A; Sharma S
    Age Ageing; 2006 Jan; 35(1):91-4. PubMed ID: 16364943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.